Regenxbio (RGNX) Other Non Operating Income (2014 - 2016)

Regenxbio's Other Non Operating Income history runs 11 years deep, the most recent figure standing at $18000.0 for Q4 2025.

• In Q4 2025, Other Non Operating Income fell 78.31% year-over-year to $18000.0; the TTM figure through Dec 2025 stood at $83000.0 (down 52.3% YoY), while the FY2025 annual figure was $83000.0, down 52.3% from the prior year.
• Other Non Operating Income for Q4 2025 stood at $18000.0, down from $19000.0 in the prior quarter.
• The five-year high for Other Non Operating Income was $14.3 million in Q4 2023, with the low at $18000.0 in Q3 2022.
• The 5-year median for Other Non Operating Income is $38500.0 (2023), against an average of $787650.0.
• The sharpest annual moves came in 2023 and 2024: Other Non Operating Income soared 18431.17% in 2023, then slumped 99.42% in 2024.
• Regenxbio's Other Non Operating Income stood at $19000.0 in 2021, then surged by 305.26% to $77000.0 in 2022, then jumped by 18431.17% to $14.3 million in 2023, then plunged by 99.42% to $83000.0 in 2024, then sank by 78.31% to $18000.0 in 2025.
• Business Quant data shows RGNX's Other Non Operating Income at $18000.0 in Q4 2025, $19000.0 in Q3 2025, and $21000.0 in Q2 2025.